Munakata M, Imai Y, Hashimoto J, Sakuma H, Sekino H, Abe K, Yoshinaga K
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai.
Tohoku J Exp Med. 1992 Feb;166(2):217-27. doi: 10.1620/tjem.166.217.
The effects of once-daily administration of calcium (Ca) channel blockers, beta-blockers and and angiotensin-converting enzyme (ACE) inhibitors on circadian rhythms of blood pressure (BP) and heart rate (HR) were studied using the cosinor method. Sixty-two recruited patients with essential hypertension (WHO stage I or II) were divided into three groups based on the class of administered drugs. In the Ca channel blocker group (n = 37, age 54 +/- 9.0 years), 18 patients were given YM 730 at a mean dose of 11 +/- 4.0 mg/day (mean +/- S.D.), 8 were given nitrendipine (11 +/- 6.7 mg/day), and 11 were given nisoldipine (8 +/- 6.4 mg/day). In the beta-blocker group (n = 15, age 42 +/- 13.5 years), 13 patients were given atenolol (44 +/- 11.0 mg/day), 1 was given nadolol (30 mg/day), and 1 was given sustained-release propranolol (60 mg/day). In the ACE inhibitor group (n = 10, age 56 +/- 8.7 years), 7 patients were given enalapril (6 +/- 2.8 mg/day), and 3 were given lisinopril (20 mg/day). Ambulatory BP monitoring (ABPM) was performed before and during treatment. Mean arterial pressure (MAP) and HR were monitored under ambulatory conditions every five minutes for 24 hr with a finger volume oscillometric device. In all three groups, the mesor of MAP decreased significantly, while the amplitude and acrophase did not change during treatment. beta-Blockers reduced the amplitude as well as the mesor of HR. Ca channel blockers increased the amplitude of HR without influencing the mesor. ACE inhibitors had no effect on the circadian rhythm parameters of HR. These results suggest that Ca channel blockers, beta-blockers and ACE inhibitors lowered BP throughout the day without changing the circadian BP rhythm. However, the three drug classes may have different influences on the autonomic nervous system that regulates circadian cardiac rhythm.
采用余弦分析方法研究了每日一次服用钙通道阻滞剂、β受体阻滞剂和血管紧张素转换酶(ACE)抑制剂对血压(BP)和心率(HR)昼夜节律的影响。62例招募的原发性高血压患者(WHO I期或II期)根据所服用药物的类别分为三组。在钙通道阻滞剂组(n = 37,年龄54±9.0岁),18例患者服用YM 730,平均剂量为11±4.0mg/天(平均值±标准差),8例服用尼群地平(11±6.7mg/天),11例服用尼索地平(8±6.4mg/天)。在β受体阻滞剂组(n = 15,年龄42±13.5岁),13例患者服用阿替洛尔(44±11.0mg/天),1例服用纳多洛尔(30mg/天),1例服用缓释普萘洛尔(60mg/天)。在ACE抑制剂组(n = 10,年龄56±8.7岁),7例患者服用依那普利(6±2.8mg/天),3例服用赖诺普利(20mg/天)。在治疗前和治疗期间进行动态血压监测(ABPM)。使用手指容积示波装置在动态条件下每五分钟监测一次平均动脉压(MAP)和HR,持续24小时。在所有三组中,MAP的中值显著降低,而在治疗期间振幅和峰相位没有变化。β受体阻滞剂降低了HR的振幅以及中值。钙通道阻滞剂增加了HR的振幅,而不影响中值。ACE抑制剂对HR的昼夜节律参数没有影响。这些结果表明,钙通道阻滞剂、β受体阻滞剂和ACE抑制剂可全天降低血压,而不改变血压的昼夜节律。然而,这三类药物可能对调节昼夜心脏节律的自主神经系统有不同的影响。